Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)
University of Texas at Austin · with National Pork Board · NCT07480109
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 30–60 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 75
- US sites recruiting
- 1
- Study start
- June 1, 2026
- Record last updated
- June 9, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Middle-aged women with (overweight/)obesity who will begin or have begun GLP-1 medication use will be recruited to complete a 12-week diet intervention study. For 12-weeks, participants will continue to take their GLP-1 medication and may be provided with protein-rich foods to consume every day. Body composition, eating behavior, health, and well-being will be measured before and after the study.
Being studied: Protein Rich Foods
Conditions: Obesity; Women (Between 30 to 60 Years Old)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adult women (30-60 years)
- Having overweight or obesity (BMI >25 kg/m2)
- Prescribed or taking GLP-1 medicine (within 4 weeks) by a physician
- Willing and able to maintain current inactivity patterns throughout the study
- Willing and able to follow all study procedures
- Generally healthy, as assessed from the medical history questionnaire
Exclusion Criteria
- Adults (\<30 years or >60 years)
- Having normal weight (BMI \<25 kg/m2)
- Not prescribed GLP-1 medication by a physician
- Those on GLP-1 medication longer than 4 weeks (during time of screening)
- Currently on a high-protein or other specific diet
- Unwilling and/or unable to maintain current inactivity patterns throughout the study
- Unwilling and/or unable to follow all study procedures
- Unwilling and/or unable to eat pork (for the GLP-1 + Protein group)
- Not generally healthy, as assessed from the medical history questionnaire
Recruiting US locations
Dell Pediatric Research Center
Austin, TX 78723
Site contact: Heather Leidy, PhD, FASN · 573-825-2620 · Leidy.Lab@austin.utexas.edu
Study contacts (from the official record)
- Heather Leidy, PhD, FASN · 5738252620 · Heather.Leidy@austin.utexas.edu
Similar studies in Texas
All weight loss studies in Texas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- Dallas, TX + 1 other US site
- Eligibility basics
- Ages 18–60 · Women only
- RecruitingHealthy volunteersPhase 1
A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy
Eli Lilly and Company
- Location
- Dallas, TX + 1 other US site
- Eligibility basics
- Ages 18–65